CYCN (STOCKS)
Cyclerion Therapeutics, Inc. Common Stock
$1.220000
+0.050000 (+4.27%)
Prev close: $1.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Regina Graul
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.18M
- Employees
- 1
- P/E (TTM)
- -1.61
- P/B (TTM)
- 0.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.30 | $0.00 | +0.0000 | +0.00% |
|
Jun 2025 (Q2)
|
$-0.11 | $0.00 | +0.0000 | +0.00% |
|
Sep 2023 (Q3)
|
$-0.93 | $-0.34 | -0.5934 | -176.29% |
|
Sep 2022 (Q3)
|
$-4.80 | $-6.32 | +1.5240 | +24.10% |
Financial Statements
| Revenues | $2.86M |
| Benefits Costs and Expenses | $5.05M |
| Costs And Expenses | $5.05M |
| Nonoperating Income/Loss | $1.43M |
| Operating Expenses | $6.49M |
| Research and Development | $496.00K |
| Other Operating Expenses | $5.99M |
| Operating Income/Loss | -$3.63M |
| Income/Loss From Continuing Operations After Tax | -$2.20M |
| Income/Loss From Continuing Operations Before Tax | -$348.00K |
| Net Income/Loss | -$2.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.75 |
| Diluted Earnings Per Share | -$0.75 |
| Basic Average Shares | 8,860,000 |
| Diluted Average Shares | 8,860,000 |
| Assets | $10.42M |
| Current Assets | $5.07M |
| Prepaid Expenses | $386.00K |
| Other Current Assets | $4.68M |
| Noncurrent Assets | $5.35M |
| Fixed Assets | $0.00 |
| Liabilities | $877.00K |
| Current Liabilities | $877.00K |
| Accounts Payable | $480.00K |
| Wages | $100.00K |
| Other Current Liabilities | $297.00K |
| Noncurrent Liabilities | $0.00 |
| Commitments and Contingencies | $0.00 |
| Equity | $9.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.54M |
| Liabilities And Equity | $10.42M |
| Net Cash Flow From Operating Activities | -$1.38M |
| Net Cash Flow From Operating Activities, Continuing | -$1.38M |
| Net Cash Flow From Investing Activities | -$1.34M |
| Net Cash Flow From Financing Activities | $3.07M |
| Exchange Gains/Losses | $0.00 |
| Net Cash Flow | $360.00K |
| Net Cash Flow, Continuing | $360.00K |
| Comprehensive Income/Loss | -$2.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.20M |
| Other Comprehensive Income/Loss | -$976.00K |